Bédard S, Marcotte B, Marette A
Department of Physiology and Lipid Research Unit, Laval University Hospital Research Center, Ste-Foy, Québec, Canada G1V 4G2.
Biochem J. 1997 Jul 15;325 ( Pt 2)(Pt 2):487-93. doi: 10.1042/bj3250487.
The principal goal of the present study was to test the hypothesis that cytokines modulate glucose transport in skeletal muscle by increasing nitric oxide production. Cultured L6 skeletal muscle cells were incubated in the presence of tumour necrosis factor-alpha, interferon-gamma or lipopolysaccharide (LPS) alone or in combination for 24 h. Neither cytokines nor LPS alone induced NO production, as measured by nitrite concentrations in the medium. However, when used in combination, the two cytokines significantly stimulated NO production, and this effect was synergistically enhanced by the presence of LPS. Reverse transcriptase-PCR (RT-PCR) analysis revealed that NO release was associated with the induction of inducible (macrophage-type) NO synthase (iNOS). The increase in iNOS expression was confirmed at the protein level by Western-blot analysis and NADPH/diaphorase histochemical staining. Cytokines and LPS markedly increased basal glucose transport in L6 myocytes. Insulin also stimulated basal glucose transport, but significantly less in cells chronically exposed to cytokines/LPS. The sensitivity of L6 muscle cells to insulin-stimulated glucose transport was also significantly decreased by cytokines/LPS treatment. The NOS inhibitor NG-nitro-l-arginine methyl ester (l-NAME) inhibited nitrite production in cytokine/LPS-treated cells, and this prevented the increase in basal glucose transport and restored muscle cell responsiveness to insulin. Cytokines/LPS exposure significantly increased GLUT1 transporter protein levels but decreased GLUT4 expression in L6 cells. l-NAME treatment prevented the increase in GLUT1 protein content but failed to restore GLUT4 transporter levels. These results demonstrate that cytokines and LPS affect glucose transport and insulin action by inducing iNOS expression and NO production in skeletal muscle cells. The data further indicate that cytokines and LPS increase the expression of the GLUT1 transporter protein by an NO-dependent mechanism.
本研究的主要目的是验证细胞因子通过增加一氧化氮生成来调节骨骼肌葡萄糖转运这一假说。将培养的L6骨骼肌细胞单独或联合置于肿瘤坏死因子-α、干扰素-γ或脂多糖(LPS)中孵育24小时。通过培养基中亚硝酸盐浓度测定,单独的细胞因子或LPS均未诱导一氧化氮生成。然而,两种细胞因子联合使用时可显著刺激一氧化氮生成,且LPS的存在可协同增强这一效应。逆转录聚合酶链反应(RT-PCR)分析显示,一氧化氮释放与诱导型(巨噬细胞型)一氧化氮合酶(iNOS)的诱导有关。通过蛋白质印迹分析和NADPH/黄递酶组织化学染色在蛋白质水平证实了iNOS表达的增加。细胞因子和LPS显著增加L6肌细胞的基础葡萄糖转运。胰岛素也刺激基础葡萄糖转运,但在长期暴露于细胞因子/LPS的细胞中刺激作用明显较弱。细胞因子/LPS处理也显著降低了L6肌细胞对胰岛素刺激的葡萄糖转运的敏感性。一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)抑制细胞因子/LPS处理细胞中的亚硝酸盐生成,并阻止基础葡萄糖转运增加,恢复肌细胞对胰岛素的反应性。细胞因子/LPS暴露显著增加L6细胞中GLUT1转运蛋白水平,但降低GLUT4表达。L-NAME处理阻止了GLUT1蛋白含量增加,但未能恢复GLUT4转运蛋白水平。这些结果表明,细胞因子和LPS通过诱导骨骼肌细胞中iNOS表达和一氧化氮生成来影响葡萄糖转运和胰岛素作用。数据进一步表明,细胞因子和LPS通过一氧化氮依赖机制增加GLUT1转运蛋白的表达。